IBD treatment is linked to cancer

Treatment for inflammatory bowel disease may increase patients' risk of infection-related cancer, research published in The Lancet suggests.

IBD treatment was researched
IBD treatment was researched

Laurent Beaugerie and colleagues from the St Antoine Hospital in Paris studied data from 19,486 patients who had Crohn's disease or ulcerative colitis.

The patients were assessed over an average of 35 months.

The researchers found that patients' risk of developing lymphoproliferative disorders was over five times higher for those treated with thiopurines, compared with those who had never received the drugs.

Old age, male sex and longer duration of inflammatory bowel disease were also associated with an increased risk of incident lymphoproliferative disorder.

However, the absolute risk remains low, the researchers pointed out, at around 90 cases per 100,000 patients.

The researchers believe that the excess risk may be due to the inflammatory process itself, or to thiopurine exposure, or to a combination of the two.

However, they said that it was not clear whether the risk of incident lymphoproliferative disorder was also increased in patients receiving other immunosuppressants.

In addition, they do not suggest that use of thiopurines should be reconsidered.

'Extrapolating our results, the absolute cumulative risk of lymphoproliferative disorder in young patients receiving a 10-year course of thiopurines remains low (<1%) and does not undermine the positive risk-benefit ratio of these drugs,' they said.

'For elderly patients and unlimited treatment periods, the question should be addressed in dedicated studies,' they added.

GP Online recommends

Lancet Online 2009

Read more

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

London GP personally calling at-risk patients to boost COVID-19 vaccine uptake

London GP personally calling at-risk patients to boost COVID-19 vaccine uptake

London GP Dr Farzana Hussain is personally telephoning scores of patients who have...

Half of patients with possible cancer symptoms avoided contacting GP in first wave

Half of patients with possible cancer symptoms avoided contacting GP in first wave

Almost half of people who experienced potential cancer symptoms in the first wave...

GP premises need major investment to let PCNs recruit, warns BMA

GP premises need major investment to let PCNs recruit, warns BMA

Primary care networks (PCNs) are struggling to make use of hundreds of millions of...

NHS unveils £4.2m fund to tackle vaccine inequality

NHS unveils £4.2m fund to tackle vaccine inequality

CCGs with low uptake of COVID-19 vaccine in ethnic minority, marginalised or deprived...

150,000 more people with learning disabilities prioritised for COVID-19 vaccine

150,000 more people with learning disabilities prioritised for COVID-19 vaccine

Around 150,000 more people will be prioritised for COVID-19 vaccination after the...